TNF and rheumatoid arthritis: The number of circulating T helper-type 17 (Th17) cells increased significantly in RA patients after anti-TNFα therapy, suggesting that a Th17-targeted therapeutic approach may be beneficial for patients with anti-TNF-IR (26).